LPTX 2.91 (+4.68%)
US52187K1016BiotechnologyBiotechnology

Leap Therapeutics (LPTX) Financial Metrics

This table shows a selected set of financial data points of Leap Therapeutics (LPTX). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -3.98 0 -1.04 84.64M -1.14 0 -43.75M -81.4M -81.41M 70.64M
2022 -4.82 0 -0.93 50.96M -0.58 375K -49.04M -53.77M -54.6M 65.5M
2021 -4.73 0 -6.85 278.07M -0.47 1.5M -35.16M -40.16M -40.59M 114.92M
2020 -4.64 0 -4.85 133.49M -0.89 1.5M -25.96M -28.18M -27.51M 52.07M
2019 -14.57 0 -0.77 25.29M -2.48 0 -26.9M -33.01M -32.9M 3.89M
2018 -1.61 0 -12.46 288.25M -0.96 0 -26.03M -23.05M -23.14M 16.28M
2017 -3.24 0 -19.29 573.37M -1.67 0 -22.2M -29.72M -29.73M 25.74M
2016 -2.73 0 -5.07 129.9M -1.48 0 -25.48M -24.37M -25.63M 793K
2015 -1.16 0 -10.98 231.75M -0.55 0 -19.59M -20.46M -21.1M 20.97M
2014 -2.15 0 -34.03 866.03M -0.73 0 -18.24M -20.39M -25.45M 10.87M
2013 -2.46 0 0 0 -0.95 0 -10.06M -17.54M -18.32M 19M
2012 -1.04 0 0 0 0 0 -7.68M -7.11M -7.76M 15.32M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.